×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Therapeutic: Aducanumab (Aduhelm)
therapeutic
1,787 words
KG: Aducanumab
2026-03-21
kind:therapeutic
section:therapeutics
state:published
evidence:strong
Contents
Aducanumab (Aduhelm)
💊
Therapeutic Info
Name
Aducanumab (Aduhelm)
Summary
Aducanumab (Aduhelm) - the first FDA-approved anti-amyloid therapy for Alzheimer's disease
Key Genes/Proteins
AMYLOID-BETA
Related Diseases
Alzheimer'S Disease
,
ALZHEIMER'S DISEASE
Knowledge Graph
Related Hypotheses (30)
APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49
APOE Isoform Expression Across Glial Subtypes
Score: 0.48
APOE Isoform Conversion Therapy
Score: 0.44
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Astrocyte-Selective APOE4 Silencing via Lipid Nanoparticles
Score: 0.53
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.48
APOE-TREM2 Interaction Modulation
Score: 0.48
TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.39
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Multi-Modal Stress Response Harmonization
Score: 0.60
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57
Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57
Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56
Purinergic Signaling Polarization Control
Score: 0.55
Show 25 more
Related Analyses (18)
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Show 13 more
Related Experiments (8)
Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40
Multi-omics analysis of myricanol effects on gene expression
exploratory · proposed · Score: 0.88
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40
Show 3 more
See Also (12)
Alzheimer Indonesia
institution · KG edge: targets
STING Gene
gene · KG edge: inhibits
Mitochondria
entity · KG edge: activates
lecanemab
general · KG edge: targets
FUS (Redirect)
redirect · KG edge: activates
Amyloid-Related Imaging Abnormalities (ARIA)
entity · KG edge: targets
blarcamesine-axon
clinical_trial · KG edge: regulates
UPenn Observational Research Repository (NCT04715399)
clinical · Pages share 3 hypotheses
remternetug-anti-amyloid-alzheimers
clinical_trial · Pages share 3 hypotheses
nct05508789
clinical_trial · Pages share 3 hypotheses
LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy
clinical · Pages share 3 hypotheses
LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for
clinical · Pages share 3 hypotheses
Show 7 more
Knowledge Graph (7 edges)
Aducanumab
targets
Amyloid-Β
Aducanumab
inhibits
Amyloid
Aducanumab
biomarker_for
Amyloid
Aducanumab
implicated_in
Amyloid
Aducanumab
targets
AMYLOID-BETA
Aducanumab
treats
Alzheimer'S Disease
Aducanumab
treats
ALZHEIMER'S DISEASE